tirzepatide retinopathy Weight loss drugs and the eye worry, this study points to a surprising upside Tirzepatide may protect against diabetic
Description
A Simpler, Safer Approach is best: For most people using GLP-1 medications, a simple supplement strategy is best
weeks 912 reach 1.0 mg

Common adverse effects reported with Ozempic include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the injection site Hypoglycaemia : especially when used in combination with insulin or sulfonylureas (doses of these medications may need reduction to minimise this risk) [3] [14] More serious but less common risks include: Pancreatitis : patients should be advised to seek immediate medical attention if they experience severe, persistent abdominal pain [22] [23] Gallbladder disease : including cholelithiasis and cholecystitis Diabetic retinopathy complications : particularly in patients with pre-existing retinopathy Acute kidney injury : risk increases with dehydration from severe gastrointestinal side effects Thyroid C-cell tumours : observed in rodent studies, though the relevance to humans remains uncertain [3] [14] Ozempic should not be used during pregnancy and should be discontinued if pregnancy occurs

In animal models of rheumatoid arthritis and systemic lupus erythematosus, ashwagandha reduced disease activity by suppressing autoreactive T cells and inflammatory cytokines [27]

Key risks include competition and supply shortages
